Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Ajinomoto Bio-Pharma Services Garners Six 'CDMO Leadership Awards,' Further Establishing Its Industry Excellence
2024-03-12 20:00
Innovating the Future: ISoOR 2024 Annual Meeting Achieves Remarkable Success
2024-03-12 11:57
TFS HealthScience Unveils Asia Pacific Expansion, Elevating Patient Access and Innovation
2024-03-12 10:52
Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2024 AACR Annual Meeting
2024-03-12 08:00
SK Biopharmaceuticals Announces 100,000 Patients Globally Have Been Treated with Cenobamate Through Sales of XCOPRI® and ONTOZRY® in the U.S., Europe, Israel, and Canada
2024-03-12 08:00
Appointment of Dr Darren Patti to Group Chief Operating Officer
2024-03-12 05:44
ImmunAbs Announces Conclusion of Phase 1 Clinical Trial, Revealing Positive Topline Results
2024-03-11 17:00
RemeGen Presents Oral Presentation on Evaluation of Its Proprietary Disitamab Vedotin (RC48) for Cervical Cancer at ESGO 2024
2024-03-11 10:36
Innovent released the results of two clinical studies of IBI311 (an anti-IGF-1R monoclonal antibody) in oral presentations at the Asia-Pacific Academy of Ophthalmology Congress and International Congress of Endocrinology 2024
2024-03-07 11:53
Luye Pharma's Innovative Drug Zepzelca® (Lurbinectedin) Launched in Hong Kong and Macao
2024-03-07 10:11
Latest Updates of Viva Biotech's Portfolio Companies
2024-03-06 19:33
Laminar Pharmaceuticals S.A. receives recommendation from the Independent Data Monitoring Committee to advance to the next stage of CLINGLIO, the phase 2b/3 Clinical Trial of LAM561 in combination with RT and TMZ for adults with newly diagnosed glioblastoma
2024-03-06 08:45
Antengene to Present Four Preclinical Abstracts at AACR 2024, Highlighting Focus on Cancer Immunology, Targeted Agents and Novel Technology Platforms
2024-03-06 08:30
Hummingbird Bioscience to Present Two Posters on Anti-HER3 and Anti-VISTA Antibody Therapeutics at American Association for Cancer Research (AACR) Meeting 2024
2024-03-06 05:30
Zymo Research Pioneers a Breakthrough in Large-scale Animal-free RNase A Production
2024-03-05 22:00
Angel Yeast Hosts Webinar with PPTI to Promote Sustainable Development of Proteins
2024-03-05 21:00
IRBM Expands Global Reach in Drug Discovery with New Boston Office
2024-03-05 20:24
First Patient Treated in Phase 2 GvHD Trial
2024-03-05 10:08
Henlius Forecasts Profit in 2023: Achieving first full year of profitability, and ushering in a new phase of high-quality development
2024-03-04 21:19
Hybribio Calls for Raising International HPV Awareness
2024-03-04 18:47
1
23
24
25
26
27
229